Clinical Trial Update: Study of OmniGraft in Simultaneous Pancreas Kidney Recipients

View source ↗

Summary

The University of Miami terminated a clinical trial evaluating OmniGraft in simultaneous pancreas-kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Pancreatic Disease

Drugs mentioned

• OmniGraft

Snippet

Sponsor: University of Miami | Conditions: Kidney Transplant; Complications, Pancreas Disease | Status: TERMINATED